TABLE 1.
Antiproliferative activities of tested compounds.
| Entry | Compound | IC50 (µM) | ||||
|---|---|---|---|---|---|---|
| SKOV3 | BT20 | A549 | HCT116 | MRC5 | ||
| 1 | COL | 11.58 ± 2.33 | 21.98 ± 1.30 | 2.39 ± 1.40 | 9.32 ± 0.2 | 5.72 ± 2.1 |
| 2 | 1E | 2.92 ± 0.28 | 7.07 ± 1.28 | >50 | >50 | >50 |
| 3 | 1Z | >50 | >50 | >50 | >50 | >50 |
| 4 | 2E | 41.58 ± 2.46 | 15.83 ± 2.90 | >50 | >50 | >50 |
| 5 | 2Z | >50 | 17.28 ± 3.44 | >50 | >50 | >50 |
| 6 | 3E | >50 | ND | >50 | >50 | >50 |
| 7 | 3Z | >50 | ND | >50 | >50 | >50 |
| 8 | 4E | >50 | ND | >50 | >50 | >50 |
| 9 | 4Z | >50 | ND | >50 | >50 | >50 |
| 10 | 5E | 3.84 ± 1.56 | 8.31 ± 1.26 | 18.85 ± 1.20 | >50 | >50 |
| 11 | 5Z | 29.81 ± 2.09 | 19.92 ± 3.42 | >50 | >50 | >50 |
| 12 | 6E | 12.44 ± 1.18 | 27.79 ± 5.31 | >50 | >50 | >50 |
| 13 | 6Z | 31.33 ± 4.42 | 12.61 ± 1.76 | >50 | >50 | >50 |
| 14 | 7E | 2.62 ± 0.53 | 10.02 ± 2.17 | 29.34 ± 1.10 | >50 | >50 |
| 15 | 7Z | >50 | >50 | >50 | >50 | >50 |
| 16 | 8E | >50 | ND | >50 | >50 | >50 |
| 17 | 8Z | >50 | ND | >50 | >50 | >50 |
| 18 | 9E | 8.08 ± 2.08 | 4.98 ± 2.77 | 21.38 ± 0.83 | >50 | >50 |
| 19 | 9Z | >50 | 20.24 ± 3.78 | >50 | >50 | >50 |
| 20 | 10E | >50 | ND | >50 | >50 | >50 |
| 21 | 10Z | >50 | ND | >50 | >50 | >50 |
| 22 | 11E | 28.85 ± 2.15 | 21.67 ± 0.67 | >50 | >50 | >50 |
| 23 | 11Z | 38.29 ± 2.31 | >50 | >50 | >50 | >50 |
| 24 | 12E | 7.35 ± 1.42 | 7.0 ± 1.96 | 9.89 ± 0.25 | 16.10 ± 1.20 | 14.39 ± 0.86 |
| 25 | 12Z | 11.93 ± 1.88 | 11.94 ± 1.10 | >50 | >50 | >50 |
ND, not determined. COL, colchicine. Bold values are numbers of synthesized compounds.